Clinical Trial Update: Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the safety and immunogenicity of a candidate HIV-1 vaccine administered to healthy infants born to HIV-1-infected mothers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 vaccine candidate

Snippet

Sponsor: Medical Research Council | Conditions: HIV-1, HIV Infections | Phase 1, Phase 2 | Status: UNKNOWN